Systemic thrombolysis in a patient with massive acute valvular thrombosis

Am J Emerg Med. 2021 Nov:49:439.e1-439.e2. doi: 10.1016/j.ajem.2021.04.061. Epub 2021 Apr 26.

Abstract

Prosthetic valve thrombosis (PVT) is considered an exceptionally rare condition, often associated with pro-thrombotic factors or suboptimal anticoagulant therapy. Guidelines recommend emergent surgery for patients with left heart valve prosthetic thrombosis who present in cardiogenic shock, and systemic thrombolysis is reserved in scenarios where surgery is not immediately available. However, several factors may affect surgical prognosis and are overlooked by current recommendations. We describe the case of a 34-year-old female who presented in the emergency department with cardiogenic shock and acute pulmonary edema due to acute valve thrombosis.

Keywords: Cardiogenic shock; Prosthetic valve thrombosis; Thrombolysis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heart Valve Prosthesis / adverse effects
  • Heart Valve Prosthesis Implantation / adverse effects
  • Heart Valves / abnormalities*
  • Heart Valves / diagnostic imaging
  • Humans
  • Thrombolytic Therapy / methods*
  • Thrombosis / drug therapy*
  • Thrombosis / physiopathology

Substances

  • Fibrinolytic Agents